Treatment of postmenopausal osteoporosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab.Case reports in rheumatology · 2013
   Article
2. Zoledronic acid: a review of its use in the treatment of osteoporosis.Drugs & aging · 2008
   Review
3. Intravenous ibandronate: in the treatment of osteoporosis.Drugs · 2006
   Review
4. Intravenous ibandronate in the treatment of osteoporosis: profile report.Drugs & aging · 2006
   Article
5. Non-pharmacological options may have role in postmenopausal osteoporosis.BMJ (Clinical research ed.) · 2003
   Article
6. Effects of Yogasanas on osteoporosis in postmenopausal women.International journal of yoga
   Article

Corrections and comments

• Commented on by
  Non-pharmacological options may have role in postmenopausal osteoporosis.2003

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as